News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
275,540 Results
Type
Article (14293)
Company Profile (106)
Press Release (261133)
Multimedia
Podcasts (65)
Webinars (13)
Section
Business (89132)
Career Advice (478)
Deals (15453)
Drug Delivery (73)
Drug Development (36796)
Employer Resources (51)
FDA (6395)
Job Trends (6264)
News (151722)
Policy (14170)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (452)
Accelerated approval (13)
Adcomms (8)
Allergies (67)
Alliances (23393)
ALS (56)
Alzheimer's disease (480)
Antibody-drug conjugate (ADC) (100)
Approvals (6586)
Artificial intelligence (201)
Autoimmune disease (39)
Automation (12)
Bankruptcy (150)
Best Places to Work (4398)
BIOSECURE Act (9)
Biosimilars (118)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (30)
Breast cancer (171)
Cancer (1322)
Cardiovascular disease (151)
Career advice (428)
Career pathing (14)
CAR-T (49)
CDC (6)
Cell therapy (150)
Cervical cancer (9)
Clinical research (32093)
Collaboration (727)
Compensation (325)
Complete response letters (33)
COVID-19 (779)
CRISPR (44)
C-suite (449)
Cystic fibrosis (58)
Data (1825)
Denatured (18)
Depression (45)
Diabetes (127)
Diagnostics (1404)
Digital health (8)
Diversity (2)
Diversity, equity & inclusion (15)
Drug discovery (113)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (80)
Earnings (33544)
Editorial (20)
Employer branding (4)
Employer resources (46)
Events (39231)
Executive appointments (553)
FDA (7494)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (430)
Gene editing (71)
Generative AI (18)
Gene therapy (167)
GLP-1 (439)
Government (1405)
Grass and pollen (4)
Guidances (164)
Healthcare (3625)
HIV (11)
Huntington's disease (9)
IgA nephropathy (37)
Immunology and inflammation (68)
Immuno-oncology (14)
Indications (53)
Infectious disease (843)
Inflammatory bowel disease (73)
Inflation Reduction Act (7)
Influenza (24)
Intellectual property (114)
Interviews (61)
IPO (5943)
IRA (33)
Job creations (2059)
Job search strategy (382)
JPM (28)
Kidney cancer (9)
Labor market (28)
Layoffs (206)
Leadership (8)
Legal (3456)
Liver cancer (22)
Longevity (8)
Lung cancer (184)
Lymphoma (123)
Machine learning (13)
Management (17)
Manufacturing (412)
MASH (67)
Medical device (1347)
Medtech (1354)
Mergers & acquisitions (9931)
Metabolic disorders (435)
Multiple sclerosis (46)
NASH (14)
Neurodegenerative disease (83)
Neuropsychiatric disorders (37)
Neuroscience (890)
Neurotech (1)
NextGen: Class of 2026 (1617)
Non-profit (616)
Now hiring (17)
Obesity (227)
Opinion (141)
Ovarian cancer (39)
Pain (109)
Pancreatic cancer (51)
Parkinson's disease (80)
Partnered (11)
Patents (221)
Patient recruitment (118)
Peanut (12)
People (30487)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8316)
Phase 2 (13561)
Phase 3 (12234)
Pipeline (1913)
Policy (135)
Postmarket research (1402)
Preclinical (3348)
Press Release (25)
Prostate cancer (84)
Psychedelics (16)
Radiopharmaceuticals (135)
Rare diseases (352)
Real estate (2663)
Recruiting (18)
Regulatory (10988)
Reports (15)
Research institute (580)
Resumes & cover letters (58)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (70)
Series A (81)
Series B (49)
Service/supplier (2)
Sickle cell disease (47)
Special edition (10)
Spinal muscular atrophy (81)
Sponsored (9)
Startups (1651)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (68)
The Weekly (45)
Vaccines (232)
Venture capital (32)
Weight loss (140)
Women's health (29)
Worklife (4)
Date
Last 7 days (178)
Last 30 days (661)
Last 365 days (10472)
2026 (961)
2025 (10781)
2024 (12583)
2023 (14349)
2022 (19646)
2021 (20191)
2020 (19152)
2019 (15046)
2018 (11818)
2017 (13960)
2016 (13191)
2015 (15536)
2014 (12469)
2013 (10689)
2012 (11503)
2011 (12025)
2010 (10965)
Location
Africa (319)
Alabama (21)
Alaska (1)
Arizona (77)
Arkansas (3)
Asia (20940)
Australia (2699)
California (3211)
Canada (1484)
China (550)
Colorado (144)
Connecticut (130)
Delaware (123)
Europe (41025)
Florida (606)
Georgia (64)
Hawaii (1)
Idaho (10)
Illinois (350)
India (44)
Indiana (240)
Iowa (2)
Japan (246)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (423)
Massachusetts (2604)
Michigan (47)
Minnesota (168)
Mississippi (1)
Missouri (33)
Montana (9)
Nebraska (7)
Nevada (18)
New Hampshire (10)
New Jersey (1398)
New Mexico (7)
New York (912)
North Carolina (628)
North Dakota (2)
Northern California (1459)
Ohio (83)
Oklahoma (6)
Oregon (19)
Pennsylvania (717)
Puerto Rico (12)
Rhode Island (17)
South America (509)
South Carolina (10)
Southern California (1401)
Tennessee (54)
Texas (461)
United States (12776)
Utah (60)
Virginia (161)
Washington D.C. (42)
Washington State (224)
West Virginia (1)
Wisconsin (37)
Wyoming (1)
275,540 Results for "acumen pharmaceuticals inc.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference 2025
November 4, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Highlights
November 13, 2025
·
12 min read
Press Releases
Acumen Pharmaceuticals Appoints George Golumbeski, Ph.D., as Chairman of its Board of Directors
November 11, 2025
·
5 min read
Press Releases
Acumen Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 12, 2025
November 5, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals to Participate in Upcoming September 2025 Investor Conferences
August 26, 2025
·
1 min read
Press Releases
Acumen Pharmaceuticals Announces First Participant Dosed in Phase 2 Open-Label Extension Study of Sabirnetug in People with Early Alzheimer’s Disease
November 18, 2025
·
5 min read
Press Releases
Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
November 19, 2025
·
7 min read
Press Releases
Acumen Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Highlights
August 12, 2025
·
13 min read
Press Releases
Acumen Pharmaceuticals Highlights Enhanced Brain Delivery™ Technology for Oligomer-Selective Antibodies and Recruitment Strategies for Phase 2 ALTITUDE-AD Clinical Trial at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
December 3, 2025
·
8 min read
Press Releases
Acumen Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 12, 2025
August 6, 2025
·
1 min read
1 of 27,554
Next
